fluoxetine has been researched along with geraniol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, XY; Fu, Q; Li, HY; Ma, SP; Ma, ZQ; Qu, R; Xue, JS | 1 |
| Adebayo, OG; Ben-Azu, B; Chidebe, EO; Chukwuma, C; Etijoro, E; Mamudu, EJ; Moke, EG; Nwangwa, EK; Omogbiya, AI; Oritsemuelebi, B; Umukoro, E | 1 |
2 other study(ies) available for fluoxetine and geraniol
| Article | Year |
|---|---|
Geraniol produces antidepressant-like effects in a chronic unpredictable mild stress mice model.
Topics: Acyclic Monoterpenes; Animals; Antidepressive Agents; Carrier Proteins; Caspase 1; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Inflammasomes; Interleukin-1beta; Male; Mice, Inbred ICR; Neuroimmunomodulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Prefrontal Cortex; Stress, Psychological; Terpenes; Uncertainty | 2015 |
Geraniol attenuates behavioral and neurochemical impairments by inhibitions of HPA-axis and oxido-inflammatory perturbations in mice exposed to post-traumatic stress disorder.
Topics: Acetylcholinesterase; Animals; Corticosterone; Disease Models, Animal; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Mice; Pituitary-Adrenal System; Stress Disorders, Post-Traumatic | 2023 |